{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:32:14Z","timestamp":1770139934078,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ygyno.2021.12.033","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T06:01:38Z","timestamp":1641362498000},"page":"607-614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Performance of human papillomavirus (HPV) mRNA testing and HPV 16 and 18\/45 genotyping combined with age stratification in the triaging of women with ASC-US cytology"],"prefix":"10.1016","volume":"164","author":[{"given":"Jiajian","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinjian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaixing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiguo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.12.033_bb0005","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","author":"Force","year":"2018","journal-title":"JAMA."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0010","first-page":"43","article-title":"Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap\/HPV cotesting in women aged 30-65 years","volume":"29","author":"Silver","year":"2018","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ygyno.2021.12.033_bb0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12916-021-02026-0","article-title":"Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study","volume":"19","author":"Zhao","year":"2021","journal-title":"BMC Med."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0020","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.7150\/jca.41472","article-title":"Diagnostic yield and performance of a large population-based cervical cancer screening program in high-risk rural China","volume":"11","author":"Wang","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.ygyno.2021.12.033_bb0025","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0030","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1309\/AJCPZ5JY6FCVNMOT","article-title":"High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study","volume":"135","author":"Stoler","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ypmed.2019.04.021","article-title":"Population-based primary HPV mRNA cervical screening compared with cytology screening","volume":"124","author":"Lindroth","year":"2019","journal-title":"Prev. Med."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0040","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jnci\/djj209","article-title":"Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial","volume":"98","author":"Ronco","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0045","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/v10120729","article-title":"Cervical cancer screening programs in Europe: the transition towards HPV vaccination and population-based HPV testing","volume":"10","author":"Chrysostomou","year":"2018","journal-title":"Viruses."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0050","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"121","author":"Massad","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J. Low Genit. Tract. Dis."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0060","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/LGT.0000000000000529","article-title":"Risk estimates supporting the 2019 ASCCP risk-based management consensus guidelines","volume":"24","author":"Egemen","year":"2020","journal-title":"J. Low Genit. Tract. Dis."},{"issue":"144","key":"10.1016\/j.ygyno.2021.12.033_bb0065","first-page":"e1","article-title":"APTIMA HPV assay performance in women with atypical squamous cells of undetermined significance cytology results","volume":"208","author":"Stoler","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0070","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2303.2011.00923.x","article-title":"Comparison of the clinical performance of an HPV mRNA test and an HPV DNA test in triage of atypical squamous cells of undetermined significance (ASC-US)","volume":"23","author":"Waldstrom","year":"2012","journal-title":"Cytopathology."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0075","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/OLQ.0000000000000970","article-title":"Accuracy of messenger RNA human papillomavirus tests for diagnostic triage of minor cytological cervical lesions: a systematic review and meta-analysis","volume":"46","author":"Macedo","year":"2019","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0080","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/ijc.26147","article-title":"HPV prevalence and accuracy of HPV testing to detect high-grade cervical intraepithelial neoplasia","volume":"130","author":"Giorgi-Rossi","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.12.033_bb0085","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1309\/AJCPLCD8TTOMLJTB","article-title":"Detection of human papillomavirus 16, 18, and 45 in women with ASC-US cytology and the risk of cervical precancer: results from the CLEAR HPV study","volume":"143","author":"Castle","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ygyno.2018.12.028","article-title":"Clinical significance of genotyping for human papillomavirus (HPV) 16 18\/45 combined with cytology in cervical exfoliated cells in HPV oncogenic mRNA-positive women","volume":"153","author":"Wang","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0095","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/jnci\/94.2.102","volume":"94","author":"Sherman","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0100","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ejca.2006.11.013","article-title":"HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology","volume":"43","author":"Ronco","year":"2007","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.12.033_bb0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1309\/AJCPGW1V2BBWMOCX","article-title":"The interplay of age stratification and HPV testing on the predictive value of ASC-US cytology. Results from the ATHENA HPV study","volume":"137","author":"Stoler","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/cncy.21521","article-title":"The pap test and Bethesda 2014","volume":"123","author":"Nayar","year":"2015","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0115","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/93.4.293","article-title":"Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial","volume":"93","author":"Solomon","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0125","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1002\/ijc.29651","article-title":"Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: results from a European multinational epidemiological study","volume":"137","author":"Holl","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.12.033_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124460","article-title":"Presence of high-risk HPV mRNA in relation to future high-grade lesions among high-risk HPV DNA positive women with minor cytological abnormalities","volume":"10","author":"Johansson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2021.12.033_bb0135","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1055\/s-0035-1558052","article-title":"Precancerous lesions of the cervix, vulva and vagina according to the 2014 WHO classification of tumors of the female genital tract","volume":"75","author":"Reich","year":"2015","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0140","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1309\/AJCP3TPHV4TRIZEK","article-title":"p16INK4a immunohistochemistry in cervical biopsy specimens: a systematic review and meta-analysis of the interobserver agreement","volume":"142","author":"Reuschenbach","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0145","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12879-015-0998-5","article-title":"Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China","volume":"15","author":"Wang","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0150","doi-asserted-by":"crossref","first-page":"14813","DOI":"10.1038\/s41598-017-13299-y","article-title":"Prevalence and genotype distribution of human papillomavirus in 961,029 screening tests in southeastern China (Zhejiang Province) between 2011 and 2015","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0155","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1158\/0008-5472.CAN-07-2754","article-title":"Type-dependent integration frequency of human papillomavirus genomes in cervical lesions","volume":"68","author":"Vinokurova","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0160","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0165","first-page":"1","article-title":"Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions","volume":"3","author":"Arbyn","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2021.12.033_bb0170","article-title":"A review of the clinical performance of the Aptima HPV assay","volume":"76","author":"Haedicke","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0175","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1309\/AJCPHVD7MIP3FYVV","article-title":"Human papillomavirus oncogenic mRNA testing for cervical cancer screening: baseline and longitudinal results from the CLEAR study","volume":"144","author":"Reid","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0180","doi-asserted-by":"crossref","first-page":"118","DOI":"10.7326\/M15-2735","article-title":"Genotyping for human papillomavirus types 16 and 18 in women with minor cervical lesions: a systematic review and meta-analysis","volume":"166","author":"Arbyn","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0185","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ygyno.2019.05.012","article-title":"Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, >\/=21years of age, with ASC-US or LSIL cytology","volume":"154","author":"Wright","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0190","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ygyno.2010.04.013","article-title":"Clinical validation of the Cervista HPV HR and 16\/18 genotyping tests for use in women with ASC-US cytology","volume":"118","author":"Einstein","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.12.033_bb0195","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ygyno.2015.06.040","article-title":"A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results","volume":"138","author":"Schiffman","year":"2015","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821017017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821017017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:00:46Z","timestamp":1758772846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821017017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0090825821017017"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.12.033","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of human papillomavirus (HPV) mRNA testing and HPV 16 and 18\/45 genotyping combined with age stratification in the triaging of women with ASC-US cytology","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.12.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}